High level serum neutralizing antibody against HIV-1 in Chinese long-term non-progressors

Microbiology and Immunology

Volumn 52, Issue 4, 2008, Pages 209-215

  Qian, Wang ^a   Hong, Shang ^a   Xiaoxu, Han ^a   Zining, Zhang ^a   Yongjun, Jiang ^a   Yanan, Wang ^a   Di, Dai ^a   Yingying, Diao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Conserved neutralization epitope; HIV; LTNP; Neutralizing antibody

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; ASSAY; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SEQUENCE ANALYSIS; BLOOD; CHINA; GENETICS; IMMUNOLOGY; MIDDLE AGED; PHYSIOLOGY; SERODIAGNOSIS; T LYMPHOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; CHINA; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNODOMINANT EPITOPES; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; RNA, VIRAL; T-LYMPHOCYTES;

EID: 55249111756     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2008.00033.x     Document Type: Article

References (25)

1. Buchbinder S.P., Katz M.H., Hessol N.A., O'Malley P.M., Holmberg S.D. (1994) Long-term HIV-1 infection without immunological progressions. AIDS 8: 1123-8.
2. Munoz A., Kirby A.J., He Y.D., Margolick J.B., Rinaldo C.R., Kaslow R.A., Phair J.P. (1995) Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4 lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 8: 496-505.
3. Sheppard H.W., Lang W., Ascher M.S., Vittinghoff E., Winkelstein W. (1993) The characterization of nonprogressors: long-term HIV-1 infection with stable CD4 T-cell levels. AIDS 7: 1159-1166.
4. Ljunggren K., Moschese V., Broliden P.A., Giaquinto C., Quinti I., Fenyo E.M., Wahren B., Rossi P., Jondal M. (1990) Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. J Infect Dis 161: 198-202.
5. Scarlatti G., Leitner T., Hodara V., Jansson M., Karlsson A., Wahlberg J., Rossi P., Uhlen M., Fenyo E.M., Albert J. (1996) Interplay of HIV-1 phenotype and neutralizing antibody response in pathogenesis of AIDS. Immunol Lett 51: 23-8.
6. Cao Y., Qin L., Zhang L., Safrit J., Ho D.D. (1995) Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 332: 201-8.
7. Karpas A., Hill F., Youle M., Cullen V., Gray J., Byron N., Hayhoe F., Tenant-Flowers M., Howard L., Gilgen D. (1988) Effects of passive immunization in patients with the acquired immunodeficiency syndrome-related complex and acquired immunodeficiency syndrome. Proc Natl Acad Sci USA 85: 9234-9237.
8. Yamanaka T., Fujimura Y., Ishimoto S., Yoshioka A., Konishi M., Narita N., Mimaya J., Mequro T., Nakasone T., Okamoto Y., Yoshizaki H., Yamada K., Honda M. (1997) Correlation of titer of antibody to principal neutralizing domain of HIV(MN) strain with disease progression in Japanese hemophiliacs seropositive for HIV type 1. AIDS Res Hum Retroviruses 13: 317-26.
9. Cecilia D., Kleeberger C., Munoz A., Giorgi J.V., Zolla-Pazner S. (1999) A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. J Infect Dis 179: 1365-74.
10. Weber J.N., Clapham P.R., Weiss R.A., Parker D., Roberts C., Duncan J., Weller I., Came C., Tedder R.S., Pinching A.J. (1987) Human immunodeficiency virus in two cohorts of homosexual men: neutralizing sera and association of anti-gag antibody with prognosis. Lancet 1: 119-22.
11. Huang Y., Zhang L., Ho D.D. (1995) Characterization of NEF sequences in long-term survivors of human immunodeficiency virus type 1 infection. J. Virol. 69: 93-100.
12. Zhang L., Huang Y., Yuan H., Tuttleton S., Ho D.D. (1997) Genetic characterization of VIF, VPR and VPU sequences from long-term survivors of human immunodeficiency virus type 1 infection. Virology 228: 340-9.
13. Wei X., Decker J.M., Wang S., Hui H., Kappes J.C., Wu X., Salazar Gonzalez J.F., Salazar M.G., Kilby J.M., Saaq M.S., Komarova N.L., Nowak M.A., Hahn B.H., Kwong P.D., Shaw G.M. (2003) Antibody neutralization and escape by HIV-1. Nature 422: 307-12.
14. Thali M., Furman C., Ho D.D., Robinson J., Tilley S., Pinter A., Sodroski J. (1992) Discontinuous, conserved neutralization epitopes overlapping the CD4 binding region of the HIV-1 gp120 envelope glycoprotein. J. Virol. 66: 5635-41.
15. Mascola J.R., Louder M.K., Winter C., Prabhakara R., De Rosa S.C., Douek D.C., Hill B.J., Gabuzda D., Roederer M. (2002) Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells. J Virol 76: 4810-21.
16. Coligan J.E., Kruisbeek A.M., Margulies D.H. (1995) Current Protocols in Immunology, Vol. 3. National Institutes of Health.
17. Ho D.D., Mckeating J.A., Li X.L., Moudqil T., Daar E.S., Sun N.C., Robinson J.E. (1991) Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody. J Virol 65: 489-93.
18. Thali M., Moore J.P., Furman C., Charles M., Ho D.D., Robinson J., Sodroski J. (1993) Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J Virol 67: 3978-88.
19. Kwong P.D., Wyatt R., Robinson J., Sweet R.W., Sodroski J., Hendrickson W.A. (1998) Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393: 648-59.
20. Trkola A., Draqic T., Arthos J., Binley J.M., Olson W.C., Allaway G.P., Cheng-Mayer C., Robinson J., Maddon P.J., Moore J.P. (1996) CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5. Nature 384: 117-8.
21. Wu L., Gerard N.P., Wyatt R., Choe H., Parolin C., Ruffing N., Borsetti A., Cardoso A.A., Desjardin E., Newman W., Gerard C., Sodroski J. (1996) CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR5. Nature 384: 179-83.
22. Sanders R.W., Venturi M., Schiffner L., Kalyanaraman R., Katinger H., Lloyd K.O., Kwong P.D., Moore J.P. (2002) The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120. J Virol 76: 7293-305.
23. Scanlan C.N., Pantophlet R., Wormald M.R., Ollmann Saphire E., Stanfield R., Wilson I.A., Katinger H., Dwek R.A., Rudd P.M., Burton D.R. (2002) The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of mannose residues on the outer face of gp120. J Virol 76: 7306-21.
24. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J.P., Katinger H. (1996) Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol 70: 1100-8.
25. Delwart E.L., Pan H., Sheppard H.W., Wolpert D., Neumann A.U., Korber B., Mullins J.I. (1997) Slower evolution of human immunodeficiency virus type 1 quasispecies during progression to AIDS. J Virol 71: 7498-508.